公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2022 | Ramucirumab for Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha Fetoprotein Following Non-Sorafenib Systemic Therapy: An Expansion Cohort of REACH-2 | Finn, Richard S; Yau, Thomas; CHIH-HUNG HSU ; De Toni, Enrico N; Goyal, Lipika; Galle, Peter R; Qin, ShuKui; Rao, Sujata; Sun, Fangfang; Wang, Chunxiao; Widau, Ryan C; Zhu, Andrew X | The oncologist | 5 | 7 | |
2022 | Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma | ANN-LII CHENG ; Qin, Shukui; Ikeda, Masafumi; Galle, Peter R; Ducreux, Michel; Kim, Tae-You; Lim, Ho Yeong; Kudo, Masatoshi; Breder, Valeriy; Merle, Philippe; Kaseb, Ahmed O; Li, Daneng; Verret, Wendy; Ma, Ning; Nicholas, Alan; Wang, Yifan; Li, Lindong; Zhu, Andrew X; Finn, Richard S | Journal of hepatology | 490 | 463 | |
2022 | Updated efficacy and safety of KEYNOTE-224: a phase II study of pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib | Kudo, Masatoshi; Finn, Richard S; Edeline, Julien; Cattan, Stéphane; Ogasawara, Sadahisa; Palmer, Daniel H; Verslype, Chris; Zagonel, Vittorina; Fartoux, Laetitia; Vogel, Arndt; Sarker, Debashis; Verset, Gontran; Chan, Stephen L; Knox, Jennifer; Daniele, Bruno; Yau, Thomas; Gurary, Ellen B; Siegel, Abby B; Wang, Anran; ANN-LII CHENG ; Zhu, Andrew X | European journal of cancer (Oxford, England : 1990) | 38 | 35 | |